Lifeward Ltd. reported a net loss for the first quarter of 2026 during an earnings call held on May 15 [1].
The financial results highlight the company's struggle to balance growth in its exoskeleton division with operational failures in its AlterG product line. These disruptions impact the firm's immediate liquidity and overall revenue trajectory as it integrates new acquisitions.
Reports on the specific net loss for the quarter vary, with figures cited between $6 million and $10.8 million [3]. Management said the revenue decline in the first quarter was due to temporary AlterG shipment disruptions caused by supply chain execution issues and working capital constraints [2].
Despite these setbacks, the company found success in other areas. ReWalk personal exoskeleton sales grew 11% year-over-year [2]. This growth suggests a steady demand for the company's mobility technology even as other product lines face logistical hurdles.
To address financial pressures, Lifeward secured $10 million in convertible note financing [4]. This capital injection follows the acquisition of Oratech, a move intended to diversify the company's offerings, and stabilize future growth.
Management provided a cautious outlook for the remainder of the year. "We expect total revenue for 2026 to be similar to 2025, with a better exit trajectory than entry," management said [5].
The earnings call, led by President and CEO Mark Grant and CFO Almog Adar, was broadcast from the company's headquarters in Hudson, Massachusetts [1]. The executives focused on the transition toward a more stable revenue stream following the recent financing and acquisition efforts.
“Our ReWalk personal exoskeleton sales grew 11% year‑over‑year.”
Lifeward is currently in a transitional phase, attempting to offset operational instability in its AlterG shipments with the growth of ReWalk and the strategic acquisition of Oratech. The reliance on a $10 million convertible note suggests a need for immediate liquidity to bridge the gap between current losses and projected year-end stability. If the 'exit trajectory' improves as management predicts, the company may stabilize its market position, but the discrepancy in reported loss figures indicates a volatile financial quarter.
